ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets

NEWARK, Del. July 28, 2022 —ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market. Used for the preparation of media, buffers, and other ingredients for biopharmaceuticals and medical devices, this launch continues to expand … Continued

ILC Dover Announces European Launch of Sentinel Clear XE™ PAPR

Sentinel Clear XE™ Hood and XE Blower deliver highest possible protection and performance for pharmaceutical and life sciences workers NEWARK, Del. [July 21, 2022] — ILC Dover Inc., specializing in innovative single-use solutions for global biotherapeutics and pharmaceutical processing as well as personal protective equipment (PPE), announced the European launch of the Sentinel Clear XE™ … Continued

ILC Dover Among Industry Team Selected to Provide the Next Generation of Spacesuits for NASA

NEWARK, Del. – June 3, 2022 – ILC Dover, the leading provider of spacesuits since the Apollo era, has been selected as part of the Collins Aerospace -led  team of industry leaders, along Oceaneering, to produce NASA’s next-generation extravehicular spacesuit. This next-generation extravehicular spacesuit could be worn by astronauts while working outside the International Space … Continued

ILC Dover Adds New European Manufacturing Location to Meet Growing Demand

New Gliwice, Poland Manufacturing Facility Expands Global Footprint in Life Sciences Market NEWARK, Del. – May 9, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to break ground on a new 90,000 sq ft manufacturing site located in … Continued

ILC Dover Announces Liquid Single-Use Bioprocessing Bags for Rapidly Growing Biotherapeutics and Cell & Gene Therapy Markets

NEWARK, Del. – March 28, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a … Continued

ILC Dover Announces North America Expansion to Meet Growing Demand

NEWARK, Del. – March 10, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business … Continued

ILC Dover Acquires KSE Scientific, a Leading Supplier of Water for Injection and Related Solutions for Biopharma, Cell & Gene Therapy, Tissue Banking and Medical Device End-Markets

Frederica, Delaware-  December 16, 2021 – ILC Dover, Inc. (“ILC Dover”, “ILC” or the “Company”), a leading designer and manufacturer of high-performance materials for life critical and primarily life sciences-based applications, today announced the acquisition of KSE Scientific (“KSE”), a sterile solutions manufacturer which specializes in the production of Water for Injection (WFI) and related … Continued

DoverPac® for HPAPI Transfers: Superior Powder Flow & Zero Cleaning

In a recent webinar, DoverPac® for HPAPI Transfers, ILC Dover discussed the two key benefits of DoverPac® technology: superior powder flow properties and zero cleaning. DoverPac® technology is a containment system that does a lot more than transfer powders. DoverPac® was purposely designed for ease of use in handling pharmaceutical products and should not be … Continued

[Webinar] DoverPac HPAPI Transfers: Zero Cleaning and Superior Powder Flow

This presentation of the DoverPac FIBC high containment system for transferring powders describes the unique capabilities in pharmaceutical processes. The DoverPac virtually eliminates cleaning resulting in cost savings and production time efficiencies. The benefits of the flexible wall technology is proven to be the best when filling and discharging poor flowing powders while promoting mass … Continued